Skip to main content
SpringerLink
Log in

Alemtuzumab-related neutropenia ups costs in renal transplantation

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab-related neutropenia ups costs in renal transplantation. Pharmacoecon. Outcomes News 606, 5 (2010). https://doi.org/10.2165/00151234-201006060-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201006060-00010

Keywords

Search

Navigation